邱琮朗 醫師．醫師代號04008

專長
‧腦血管疾病（腦中風）
‧腦瘤
‧立體定位手術

現 職
‧花蓮慈院神經醫學科學中心主任
‧花蓮慈院神經外科主治醫師
‧部定教授

學 歷
‧慈濟大學醫學研究所博士班畢業
‧中國醫藥學院醫學系畢業

經 歷
‧三軍總醫院主治醫師
‧中國醫藥學院附設醫院神經外科兼外科加護病房主任
‧花蓮慈院神經外科主任

論 文
‧Chiu TL, Huang HY, Chang HF, Wu HR, Wang MJ*. Enhanced IRE1α Phosphorylation/Oligomerization-Triggered XBP1 Splicing Contributes to Parkin-Mediated Prevention of SH-SY5Y Cell Death under Nitrosative Stress. Int J Mol Sci. Jan 19 2023;24(3).
‧Chiu TL*, Baskaran R, Tsai ST, Huang CY, Chuang MH, Syu WS, Harn HJ, Lin YC, Chen CH, Huang PC, Wang YF, Chuang CH, Lin PC, Lin SZ. Intracerebral transplantation of autologous adipose-derived stem cells for chronic ischemic stroke: A phase I study. J Tissue Eng Regen Med. Jan 2022;16(1):3-13.
‧Chiu TL, Lin SZ, Ahmed T, Huang CY, Chen CH*. Pilot study of a new type of machine vision-assisted stereotactic neurosurgery for EVD placement. Acta Neurochir (Wien). Sep 2022;164(9):2385-2393.
‧Liu CA, Harn HJ, Chen KP, Lee JH, Lin SZ, Chiu TL*. Targeting the Axl and mTOR Pathway Synergizes Immunotherapy and Chemotherapy to Butylidenephthalide in a Recurrent GBM. J Oncol. 2022;2022:3236058.
‧Liu CA, Liu WH, Ma HI, Chen YH, Hueng DY, Tsai WC, Lin SZ, Harn HJ, Chiou TW, Liu JW, Lee JH, Chiu TL*. Interstitial Control-Released Polymer Carrying a Targeting Small-Molecule Drug Reduces PD-L1 and MGMT Expression in Recurrent High-Grade Gliomas with TMZ Resistance. Cancers (Basel). Feb 18 2022;14(4).
‧Pan YH, Lin SZ, Chiu TL*. Biodegradable controlled-release polymer containing butylidenephthalide to treat a recurrent cervical spine glioblastoma with promising result: a compassionate trial report. Anticancer Drugs. Apr 1 2022;33(4):394-399.
‧Lee TK, Lu CY, Tsai ST, Tseng PH, Lin YC, Lin SZ, Wang JC, Huang CY, Chiu TL*. Complete Restoration of Motor Function in Acute Cerebral Stroke Treated with Allogeneic Human Umbilical Cord Blood Monocytes: Preliminary Results of a phase I Clinical Trial. Cell Transplant. Jan-Dec 2021;30:9636897211067447.
‧Liao KF, Chiu TL, Chang SF, Wang MJ, Chiu SC. Hispolon Induces Apoptosis, Suppresses Migration and Invasion of Glioblastoma Cells and Inhibits GBM Xenograft Tumor Growth In Vivo. Molecules. Jul 26 2021;26(15).
‧Chiu TL, Wang YJ, Chang TW, Lin SZ, Tsai ST*. Granulocyte Colony-Stimulating Factor for Treatment of Patients with Chronic Traumatic Brain Injury: A Preliminary Pre-Post Study. Brain Sci. Oct 29 2021;11(11).
‧Chang CY, Chiu TL, Chang PY, Hu CM, Wang LS*. Subdural effusion and ischemic stroke complicating meningococcal meningitis in an adult. J Microbiol Immunol Infect. Feb 2019;52(1):165-166.
‧Wang MJ, Huang HY, Chiu TL, Chang HF, Wu HR. Peroxiredoxin 5 Silencing Sensitizes Dopaminergic Neuronal Cells to Rotenone via DNA Damage-Triggered ATM/p53/PUMA Signaling-Mediated Apoptosis. Cells. Dec 19 2019;9(1).
‧Lee C-H, Tsai S-T, Chiu T-L*. Superficial temporal artery-middle cerebral artery bypass for the treatment of complex middle cerebral artery aneurysms. Tzu Chi Medical Journal. April 1, 2018 2018;30(2):110-115.
‧Liao KF, Chiu TL, Huang SY, Hsieh TF, Chang SF, Ruan JW, Chen SP, Pang CY, SC*. C. Anti-Cancer Effects of Radix Angelica Sinensis (Danggui) and N-Butylidenephthalide on Gastric Cancer: Implications for REDD1 Activation and mTOR Inhibition. Cell Physiol Biochem. 2018;48(6):2231-2246.